Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Powell

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2022
Epigenetic state determines inflammatory sensing in neuroblastomaAdam J Wolpaw, Liron D Grossmann, Jessica L Dessau, et al.
Communications Biology|November 18, 2022
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastomaMehran Makvandi, Minu Samanta, Paul Martorano, et al.
Cytotherapy|December 12, 2025
GMP-compliant manufacturing of allogeneic peripheral blood CAR-NK cells for the treatment of acute myeloid leukemiaLaura Córdoba-Espejo, Laura Sánchez-Vega, Almudena García-Ortiz, et al.
NPJ Vaccines|March 16, 2021
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancerJanos L Tanyi, Cheryl L-L Chiang, Johanna Chiffelle, et al.
NPJ Vaccines|May 5, 2021
Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancerJanos L Tanyi, Cheryl L-L Chiang, Johanna Chiffelle, et al.
Journal of Translational Medicine|July 20, 2023
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022)Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, et al.
Cancer Cell|June 12, 2019
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid TumorsDenarda Dangaj, Marine Bruand, Alizée J Grimm, et al.
Cancer Cell|December 13, 2022
Expression of inducible factors reprograms CAR-T cells for enhanced function and safetyAnže Smole, Alexander Benton, Mathilde A Poussin, et al.
Nature Cancer|September 22, 2023
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancerSara Bobisse, Valentina Bianchi, Janos L Tanyi, et al.
Molecular Cancer Therapeutics|June 30, 2026
Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability TradeoffsLouise A Koopman, Farshid Alemdehy, Stefanie A H de Poot, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2022
Epigenetic state determines inflammatory sensing in neuroblastomaAdam J Wolpaw, Liron D Grossmann, Jessica L Dessau, et al.
Communications Biology|November 18, 2022
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastomaMehran Makvandi, Minu Samanta, Paul Martorano, et al.
Cytotherapy|December 12, 2025
GMP-compliant manufacturing of allogeneic peripheral blood CAR-NK cells for the treatment of acute myeloid leukemiaLaura Córdoba-Espejo, Laura Sánchez-Vega, Almudena García-Ortiz, et al.
NPJ Vaccines|March 16, 2021
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancerJanos L Tanyi, Cheryl L-L Chiang, Johanna Chiffelle, et al.
NPJ Vaccines|May 5, 2021
Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancerJanos L Tanyi, Cheryl L-L Chiang, Johanna Chiffelle, et al.
Journal of Translational Medicine|July 20, 2023
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022)Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, et al.
Cancer Cell|June 12, 2019
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid TumorsDenarda Dangaj, Marine Bruand, Alizée J Grimm, et al.
Cancer Cell|December 13, 2022
Expression of inducible factors reprograms CAR-T cells for enhanced function and safetyAnže Smole, Alexander Benton, Mathilde A Poussin, et al.
Nature Cancer|September 22, 2023
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancerSara Bobisse, Valentina Bianchi, Janos L Tanyi, et al.
Molecular Cancer Therapeutics|June 30, 2026
Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability TradeoffsLouise A Koopman, Farshid Alemdehy, Stefanie A H de Poot, et al.
Pageof 14